Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2013-001231-51Phase 3Completed
Phase 3 trial of influenza vaccine in influenza (2 arms), sponsored by Sanofi. Primary endpoint: Incidence of laboratory-confirmed influenza associated with protocol-defined influenza-like illness. Started Mar 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2013-001231-51.